Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Latisse Generic Name & Formulations
Legal Class
Rx
General Description
Bimatoprost 0.03%; oph soln; contains benzalkonium chloride.
Pharmacological Class
Prostaglandin analogue.
How Supplied
Soln—3mL, 5mL (w. disposable sterile applicators)
Manufacturer
Generic Availability
YES
Latisse Indications
Indications
Hypotrichosis of the eyelashes.
Latisse Dosage and Administration
Adult
1 drop once nightly; apply evenly along upper eyelid skin margin at the base of eyelashes. Repeat for opposite eyelid margin with new sterile applicator. Blot any excess solution runoff.
Children
Not recommended.
Latisse Contraindications
Not Applicable
Latisse Boxed Warnings
Not Applicable
Latisse Warnings/Precautions
Warnings/Precautions
Do not apply to lower eyelash line. Repeated contact with bimatoprost outside the treatment area may cause hair growth. Ocular hypertension; monitor for changes to intraocular pressure. Intraocular inflammation (eg, uveitis). Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Contact lenses (remove; may reinsert lenses 15 mins after administration). Pregnancy. Nursing mothers.
Latisse Pharmacokinetics
See Literature
Latisse Interactions
Interactions
Concomitant with other intraocular pressure (IOP)-lowering prostaglandin analogues may decrease IOP-lowering effects.
Latisse Adverse Reactions
Adverse Reactions
Eye pruritus, conjunctival hyperemia, skin pigmentation, ocular irritation, dry eye symptoms, periorbital erythema, foreign body sensation, abnormal hair growth, iris hyperpigmentation, others.
Latisse Clinical Trials
See Literature
Latisse Note
Not Applicable
Latisse Patient Counseling
See Literature
